PMGC Holdings Inc.
- ELAB
- NASDAQ
- Biotechnology
- Engineered Probiotics
- Microbiome Therapeutics
$2.77
Today −8.88%Quote Oct 16, 2026, 08:00 PM UTC
−41.31%over the last month
Max drawdown −42.1%From 1-month high −42.1%3 months −74.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$22.4M
Quote Oct 16
Next earnings
—
Data unavailable
Latest analyst target
—
Data unavailable
Floor
$2.63
4.9% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ELABPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
33